๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer

โœ Scribed by Jiunn-Liang Ko; Ya-Wen Cheng; Shu-Lin Chang; Jen-Ming Su; Chih-Yi Chen; Huei Lee

Publisher
John Wiley and Sons
Year
2000
Tongue
French
Weight
255 KB
Volume
89
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

KAI1/CD82 expression in nonsmall cell lu
KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor : An immunohistochemical analysis
โœ Masahiko Higashiyama; Ken Kodama; Hideoki Yokouchi; Koji Takami; Masashi Adachi; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 244 KB ๐Ÿ‘ 2 views

## BACKGROUND. The KAI1/CD82 gene, the product of which is a member of the transmembrane-4 superfamily, is a suppressor of metastasis; as a result, it is inversely associated with tumor progression and is a favorable prognostic factor in some tumors. This study was performed to determine the progn

Differential expression of matrix metall
Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer
โœ Thomas, Pascal; Khokha, Rama; Shepherd, Frances A.; Feld, Ronald; Tsao, Ming-Sou ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 208 KB ๐Ÿ‘ 2 views

In a comprehensive immunohistochemical study of the expression of ten metalloproteinases (MMPs) and their four inhibitors (TIMPs) in 115 non-small cell lung carcinomas (NSCLCs), the ยฎndings have been correlated with the histological and clinical features of the tumours. All MMPs and TIMPs were expre

Quantitative analysis of p53 protein in
Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value
โœ Michael A. Levesque; Mario D'Costa; Ernest H. Spratt; Mohammad M. Yaman; Elefthe ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 99 KB ๐Ÿ‘ 2 views

Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu

CD80 expression in an HLA-A2-positive hu
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer
โœ Dale L. Bixby; John R. Yannelli ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 185 KB ๐Ÿ‘ 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix